ECV - Epihunter Clinical Validation
ECV
1 other identifier
interventional
102
4 countries
4
Brief Summary
The goal of this prospective study is to validate a wearable EEG seizure detection solution compared to video EEG. Subjects that undergo a clinical video EEG are asked to additionally wear a wearable EEG headband for up to 2 periods of 4h during the video EEG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 14, 2020
CompletedFirst Posted
Study publicly available on registry
November 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedApril 4, 2022
April 1, 2022
1.2 years
September 14, 2020
April 1, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Sensitivity for electrographic seizures of study device compared to video EEG
The sensitivity for electrographic seizures by the study device compared to manually annotated electrographic seizures on non-video EEG is \> 0.90 (median sensitivity per patient)
9 months
Number of false alarms by study device per hour
The number of false alarms by the study device \< 0.1 per hour (median false detection rate per recording)
9 months
Secondary Outcomes (1)
Feasibility testing of automated behavioral testing triggered by automated detection
3 months
Study Arms (1)
All subjects
EXPERIMENTALSubjects that undergo a clinical video EEG are asked to additionally wear a wearable EEG headband for up to 2 periods of 4h during the video EEG.
Interventions
Eligibility Criteria
You may qualify if:
- Subjects should have an indication of having absence seizures
- Subjects should be admitted for video EEG monitoring as part of their clinical practice
- Age \> 4 years
You may not qualify if:
- Head circumference should be compatible for wearable EEG device (40-70cm)
- The subject should be able to understand instructions and refrain from removing the device from its head
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Epihunter NVlead
- Filadelfia Epilepsy Hospitalcollaborator
- KU Leuvencollaborator
- Boston Children's Hospitalcollaborator
- Institute of Neurology and Neuropsychology, Tbilisi, Georgiacollaborator
Study Sites (4)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
UZ Leuven
Leuven, Belgium
Danish Epilepsy Center
Dianalund, Denmark
Institute of Neurology and Neuropsychology
Tbilisi, Georgia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dirk Loeckx, PhD
Epihunter NV
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2020
First Posted
November 4, 2020
Study Start
May 1, 2020
Primary Completion
June 28, 2021
Study Completion
December 31, 2021
Last Updated
April 4, 2022
Record last verified: 2022-04